Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology
暂无分享,去创建一个
G. Filippatos | A. Mebazaa | L. Lund | M. Metra | A. Bayés‐Genís | J. Čelutkienė | P. Seferovic | F. Ruschitzka | S. Adamopoulos | A. Mortara | T. McDonagh | C. Hassager | M. Cicoira | J. Bauersachs | E. Barbato | A. Chieffo | I. Ahrens | S. Collins | J. Bartunek | S. Price | M. Yılmaz | W. Mullens | V. Harjola | L. Hill | K. Damman | A. Vahanian | A. Coats | J. Masip | T. Ben‐Gal | F. Gustafsson | M. Nikolaou | M. Adamo | H. Skouri | O. Chioncel | V. Iliescu | E. Antohi | J. Parissis | A. Almaghraby | P. Paolisso | A. Ristić | S. Anker | B. Moura | M. Abdelhamid | Òscar Miró | A. Rakisheva | R. Vidal-Pérez | K. Huber | G. Rosano | Ewa A. Janowska | Ò. Miró | Giuseppe M C Rosano | Arsen Ristić
[1] M. Enriquez-Sarano,et al. Unmet needs in valvular heart disease. , 2023, European heart journal.
[2] M. Price,et al. Transcatheter Repair for Patients with Tricuspid Regurgitation. , 2023, The New England journal of medicine.
[3] D. Dudek,et al. Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery. , 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[4] S. Russell,et al. Surgical Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricular Assist Device Implantation: Interim analysis of the TVVAD trial. , 2022, The Journal of thoracic and cardiovascular surgery.
[5] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.
[6] P. Colonna,et al. Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry , 2022, European heart journal.
[7] C. Otto,et al. Transcatheter interventions spark a paradigm change for management of patients with mixed valve disease. , 2022, European heart journal.
[8] F. Ruschitzka,et al. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. , 2022, European heart journal.
[9] A. Unbehaun,et al. Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation? , 2022, European heart journal.
[10] S. Gündüz,et al. Thrombolysis or Surgery in Patients With Obstructive Mechanical Valve Thrombosis: The Multicenter HATTUSHA Study. , 2022, Journal of the American College of Cardiology.
[11] H. Thiele,et al. Right Ventricular-Pulmonary Arterial Coupling and Afterload Reserve in Patients Undergoing Transcatheter Tricuspid Valve Repair. , 2022, Journal of the American College of Cardiology.
[12] M. Metra,et al. Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? , 2021, European journal of heart failure.
[13] V. Galusko,et al. Management of mitral stenosis: a systematic review of clinical practice guidelines and recommendations. , 2021, European heart journal. Quality of care & clinical outcomes.
[14] B. Prendergast,et al. Transcatheter treatment for tricuspid valve disease. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[15] B. Iung,et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery , 2021, European heart journal.
[16] A. Zaman,et al. ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial. , 2021, JACC. Cardiovascular interventions.
[17] D. Dvir,et al. Conservative, surgical, and percutaneous treatment for mitral regurgitation shortly after acute myocardial infarction. , 2021, European heart journal.
[18] J. McMurray,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.
[19] E. Agricola,et al. Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target? , 2021, Frontiers in Cardiovascular Medicine.
[20] P. Ponikowski,et al. Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF , 2021, European journal of heart failure.
[21] J. Prillinger,et al. Survival Following Edge‐to‐Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nationwide Analysis , 2021, Journal of the American Heart Association.
[22] D. Bandyopadhyay,et al. Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[23] A. Colombo,et al. Use of edge‐to‐edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA‐SHOCK study) , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] S. Janssens,et al. Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week. , 2021, Journal of the American College of Cardiology.
[25] Y. Agmon,et al. Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry) , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[26] B. Pierce,et al. Impact of Pre-Existing Mitral Regurgitation Following Left Ventricular Assist Device Implant. , 2021, Seminars in thoracic and cardiovascular surgery.
[27] M. Mack,et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. , 2020, Journal of the American College of Cardiology.
[28] M. Metra,et al. COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation. , 2020, JACC. Cardiovascular interventions.
[29] S. Davies,et al. Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to MitraClip®-procedure: a new option for critically ill patients. , 2020, European heart journal. Acute cardiovascular care.
[30] M. Vaduganathan,et al. Prevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study. , 2020, JACC. Heart failure.
[31] H. Thiele,et al. Arterial Lactate in Cardiogenic Shock: Prognostic Value of Clearance Versus Single Values. , 2020, JACC. Cardiovascular interventions.
[32] C. Don,et al. Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis. , 2020, JACC. Cardiovascular interventions.
[33] R. Hullin,et al. Non‐severe aortic regurgitation increases short‐term mortality in acute heart failure with preserved ejection fraction , 2020, ESC heart failure.
[34] A. Kutikhin,et al. Degeneration of Bioprosthetic Heart Valves: Update 2020 , 2020, Journal of the American Heart Association.
[35] F. Rutten,et al. Integration of a palliative approach into heart failure care: a European Society of Cardiology Heart Failure Association position paper , 2020, European journal of heart failure.
[36] D. Newby,et al. Clinical outcomes following balloon aortic valvuloplasty , 2020, Open Heart.
[37] A. Kosinski,et al. Demographics, Procedural Characteristics, and Clinical Outcomes When Cardiogenic Shock Precedes TAVR in the United States. , 2020, JACC. Cardiovascular interventions.
[38] G. Filippatos,et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.
[39] D. Hildick-Smith,et al. Balloon aortic valvuloplasty: indications, patient eligibility, technique and contemporary outcomes , 2020, Heart.
[40] L. Räber,et al. Does isolated mitral annular calcification in the absence of mitral valve disease affect clinical outcomes after transcatheter aortic valve replacement? , 2020, European heart journal cardiovascular Imaging.
[41] R. Levine,et al. Secondary valve regurgitation in patients with heart failure with preserved ejection fraction, heart failure with mid-range ejection fraction, and heart failure with reduced ejection fraction. , 2020, European heart journal.
[42] A. Boyle,et al. Pulmonary Hypertension Due to Left Heart Disease: Diagnosis, Pathophysiology, and Therapy. , 2020, Hypertension.
[43] C. Rihal,et al. Structural Heart Disease Emergencies , 2020, Journal of intensive care medicine.
[44] J. Cleveland,et al. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[45] K. Dickstein,et al. Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study. , 2020, The Lancet. Global health.
[46] M. Metra,et al. Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock. , 2020, Journal of cardiovascular medicine.
[47] M. Carrier,et al. Continuous-Flow Left Ventricular Assist Devices and Valvular Heart Disease: A Comprehensive Review. , 2020, The Canadian journal of cardiology.
[48] H. Thiele,et al. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry. , 2020, JACC. Cardiovascular interventions.
[49] K. Dickstein,et al. Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure. , 2020, JAMA cardiology.
[50] A. Íñiguez,et al. The European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI). , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[51] C. Ruiz,et al. Mechanical Circulatory Support in Transcatheter Aortic Valve Implantation in the United States (from the National Inpatient Sample). , 2019, The American journal of cardiology.
[52] P. Ponikowski,et al. Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry , 2019, European journal of heart failure.
[53] E. Cohen,et al. Transcatheter Mitral Valve Edge-to-Edge Repair with the New MitraClip XTR System for Acute Mitral Regurgitation Caused by Papillary Muscle Rupture. , 2019, The Canadian journal of cardiology.
[54] O. Alfieri,et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. , 2019, European heart journal.
[55] H. Thiele,et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. , 2019, European heart journal.
[56] J. Lupón,et al. Functional tricuspid regurgitation and recurrent admissions in patients with acute heart failure. , 2019, International journal of cardiology.
[57] Jeroen J. Bax,et al. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. , 2019, Circulation.
[58] Jeroen J. Bax,et al. Prognostic Implications of Right Ventricular Remodeling and Function in Patients with Significant Secondary Tricuspid Regurgitation. , 2019, Circulation.
[59] F. Leclercq,et al. Management of valvulopathies with acute severe heart failure and cardiogenic shock. , 2019, Archives of cardiovascular diseases.
[60] S. Rosenkranz,et al. Pulmonary hypertension and valvular heart disease , 2019, Herz.
[61] P. Rajiah,et al. Magnetic resonance imaging of the papillary muscles of the left ventricle: normal anatomy, variants, and abnormalities , 2019, Insights into Imaging.
[62] Y. Agmon,et al. Salvage MitraClip in severe secondary mitral regurgitation complicating acute myocardial infarction: data from a multicentre international study , 2019, European journal of heart failure.
[63] A. Mebazaa,et al. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes , 2019, European journal of heart failure.
[64] G. Filippatos,et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations , 2019, European journal of heart failure.
[65] R. Beeri,et al. Utilization of intra-aortic balloon pump to allow MitraClip procedure in patients with non-coapting mitral valve leaflets: a case series , 2019, European heart journal. Case reports.
[66] D. Sánchez-Quintana,et al. Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.
[67] R. Siegel,et al. Rheumatic Mitral Valve Stenosis: Diagnosis and Treatment Options , 2019, Current Cardiology Reports.
[68] C. Hengstenberg,et al. Natural History of Functional Tricuspid Regurgitation: Implications of Quantitative Doppler Assessment. , 2019, JACC. Cardiovascular imaging.
[69] T. Hryniewiecki,et al. The usefulness of cardiac CT in the diagnosis of perivalvular complications in patients with infective endocarditis , 2019, European Radiology.
[70] S. Achenbach,et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI) / transcatheter aortic valve replacement (TAVR): An expert consensus document of the Society of Cardiovascular Computed Tomography. , 2019, Journal of cardiovascular computed tomography.
[71] T. Maruo,et al. Dynamic severe mitral regurgitation on hospital arrival as prognostic predictor in patients hospitalized for acute decompensated heart failure. , 2018, International journal of cardiology.
[72] Catalin Loghin,et al. Paravalvular leak , 2018, ASVIDE.
[73] A. Colombo,et al. Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less. , 2018, The American journal of cardiology.
[74] J. Bucerius,et al. Improving the Diagnostic Performance of 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis , 2018, Circulation.
[75] M. Guerrero,et al. Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. , 2018, Cardiovascular revascularization medicine : including molecular interventions.
[76] J. Rouleau,et al. Aortic regurgitation in patients with a left ventricular assist device: A contemporary review. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[77] D. Morrow,et al. Positive Pressure Ventilation in the Cardiac Intensive Care Unit. , 2018, Journal of the American College of Cardiology.
[78] J. Lessick,et al. Tricuspid regurgitation in acute heart failure: is there any incremental risk? , 2018, European heart journal cardiovascular Imaging.
[79] S. Windecker,et al. Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation. , 2018, The American journal of cardiology.
[80] D. Maucort-Boulch,et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.
[81] G. Lemesle,et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[82] K. Ellenbogen,et al. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads , 2018, Pacing and clinical electrophysiology : PACE.
[83] H. Ojiri,et al. Cardiac computed tomography as a viable alternative to echocardiography to detect vegetations and perivalvular complications in patients with infective endocarditis , 2018, Japanese Journal of Radiology.
[84] I. Palacios,et al. The Role of Impella for Hemodynamic Support in Patients With Aortic Stenosis , 2018, Current Treatment Options in Cardiovascular Medicine.
[85] U. Laufs,et al. Mitral valve interventions in heart failure , 2018, ESC heart failure.
[86] G. Hanzel,et al. Emergency Valve-in-Valve Transcatheter Aortic Valve Implantation for the Treatment of Acute Stentless Bioprosthetic Aortic Insufficiency and Cardiogenic Shock , 2018, Case reports in cardiology.
[87] C. Ramasamy,et al. Outcomes following balloon mitral valvuloplasty in pregnant females with mitral stenosis and significant sub valve disease with severe decompensated heart failure , 2018, Journal of interventional cardiology.
[88] Masashi Tanaka,et al. Strategy for Porcelain Ascending Aorta in Cardiac Surgery. , 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[89] I. Palacios,et al. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry. , 2018, JACC. Cardiovascular interventions.
[90] B. Iung,et al. Management of atrial fibrillation in patients with rheumatic mitral stenosis , 2018, Heart.
[91] Jong-Min Song,et al. Demonstration of infective endocarditis by cardiac CT and transoesophageal echocardiography: comparison with intra-operative findings , 2018, European heart journal cardiovascular Imaging.
[92] M. Srivastava,et al. Acute Valvular Heart Disease. , 2018, Cardiology clinics.
[93] F. Fernández‐Avilés,et al. Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial , 2017, European heart journal.
[94] Jeroen J. Bax,et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation. , 2017, Journal of the American College of Cardiology.
[95] A. Vahanian,et al. Effectiveness of Rescue Percutaneous Balloon Aortic Valvuloplasty in Patients With Severe Aortic Stenosis and Acute Heart Failure. , 2017, The American journal of cardiology.
[96] G. Filippatos,et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long‐Term Registry , 2017, European journal of heart failure.
[97] N. Moat,et al. Mechanism and Implications of the Tricuspid Regurgitation: From the Pathophysiology to the Current and Future Therapeutic Options , 2017, Circulation. Cardiovascular interventions.
[98] D. Raoult,et al. Coronary events complicating infective endocarditis , 2017, Heart.
[99] R. Lange,et al. Emergency treatment of decompensated aortic stenosis , 2017, Heart.
[100] M. Metra,et al. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. , 2017, International journal of cardiology.
[101] J. Leipsic,et al. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement. , 2017, Journal of the American College of Cardiology.
[102] J. Smith,et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study , 2017, Heart.
[103] D. Berman,et al. Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis. , 2017, JACC. Cardiovascular imaging.
[104] G. Filippatos,et al. European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions , 2016, European journal of heart failure.
[105] M. Metra,et al. Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? , 2016, European journal of heart failure.
[106] K. Kuck,et al. Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[107] J. Zamorano,et al. [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)]. , 2016, Giornale italiano di cardiologia.
[108] G. Filippatos,et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology , 2016, European journal of heart failure.
[109] J. McClung. Native and Prosthetic Valve Emergencies , 2016, Cardiology in review.
[110] A. Vahanian,et al. Multiple valve disease - assessment, strategy and intervention. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[111] W. Fares,et al. Management of Right Heart Failure in the Intensive Care Unit. , 2015, Clinics in chest medicine.
[112] M. García-González,et al. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study. , 2015, Cardiovascular therapeutics.
[113] E. Núñez,et al. Tricuspid Regurgitation and Mortality Risk Across Left Ventricular Systolic Function in Acute Heart Failure. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[114] K. Kuck,et al. MitraClip implantation after acute ischemic papillary muscle rupture in a patient with prolonged cardiogenic shock. , 2015, The Annals of thoracic surgery.
[115] Karen May-Newman,et al. Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patients with a continuous-flow left ventricular assist device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[116] A. Sillah,et al. Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. , 2015, Journal of palliative medicine.
[117] S. Dunlay,et al. Impact of Tricuspid Valve Surgery at the Time of Left Ventricular Assist Device Insertion on Postoperative Outcomes , 2015, ASAIO journal.
[118] B. Strauss,et al. MitraClip for papillary muscle rupture in patient with cardiogenic shock. , 2014, The Canadian journal of cardiology.
[119] G. Eslick,et al. Transcatheter valve-in-valve implantation: a systematic review of literature. , 2014, Heart, lung & circulation.
[120] K. Boman,et al. Effects of person‐centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study , 2014, European journal of heart failure.
[121] Naoki Sato,et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. , 2014, Journal of the American College of Cardiology.
[122] A. Shiran,et al. Risk factors for progression of functional tricuspid regurgitation. , 2014, The American journal of cardiology.
[123] S. Hutchison,et al. Acute mitral regurgitation: unforeseen new complication of the Impella LP 5.0 ventricular assist device and review of literature. , 2014, Heart, lung & circulation.
[124] K. Chatterjee,et al. The pulmonary artery catheter: a critical reappraisal. , 2013, Cardiology clinics.
[125] G. Nickenig,et al. Transcatheter mitral valve replacement using a balloon-expandable prosthesis in a patient with calcified native mitral valve stenosis. , 2013, European heart journal.
[126] F. Verbrugge,et al. Abdominal contributions to cardiorenal dysfunction in congestive heart failure. , 2013, Journal of the American College of Cardiology.
[127] P. Leprince,et al. Prognostic Implications of Pulmonary Hypertension in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation: Study From the FRANCE 2 Registry , 2013, Circulation. Cardiovascular interventions.
[128] B. Prendergast,et al. Can we improve the detection of heart valve disease? , 2013, Heart.
[129] G. Jondeau,et al. Current aspects of the spectrum of acute heart failure syndromes in a real‐life setting: the OFICA study , 2013, European journal of heart failure.
[130] G. Maurer,et al. Impact of tricuspid regurgitation on survival in patients with chronic heart failure: unexpected findings of a long-term observational study. , 2013, European heart journal.
[131] T. Marwick,et al. Prognostic Significance of Exercise-induced Right Ventricular Dysfunction in Asymptomatic Degenerative Mitral Regurgitation , 2013, Circulation. Cardiovascular imaging.
[132] Nader Moazami,et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[133] G. Filippatos,et al. [Guidelines on the management of valvular heart disease]. , 2013, Revista espanola de cardiologia.
[134] L. Tavazzi,et al. Acute heart failure patient profiles, management and in‐hospital outcome: results of the Italian Registry on Heart Failure Outcome , 2012, European journal of heart failure.
[135] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[136] E. Donal,et al. Determinants and Prognostic Significance of Exercise Pulmonary Hypertension in Asymptomatic Severe Aortic Stenosis , 2012, Circulation.
[137] Y. Topilsky,et al. Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices. , 2012, The Journal of thoracic and cardiovascular surgery.
[138] J. Maessen,et al. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. , 2012, The Annals of thoracic surgery.
[139] H. Michelena,et al. Clinical Context and Mechanism of Functional Tricuspid Regurgitation in Patients With and Without Pulmonary Hypertension , 2012, Circulation. Cardiovascular imaging.
[140] D. Raoult,et al. Management of infective endocarditis: challenges and perspectives , 2012, The Lancet.
[141] E. Tuzcu,et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. , 2011, The Journal of thoracic and cardiovascular surgery.
[142] M. Gheorghiade,et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. , 2011, American heart journal.
[143] M. Enriquez-Sarano,et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. , 2011, European heart journal.
[144] G. Parati,et al. Acute effects of levosimendan on mitral regurgitation and diastolic function in patients with advanced chronic heart failure , 2010, Journal of cardiovascular medicine.
[145] C. Bauters,et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation , 2010, Heart.
[146] G. Filippatos,et al. Guidelines for the diagnosis and treatment of pulmonary hypertension , 2009 .
[147] P. Varadarajan,et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. , 2009, The Annals of thoracic surgery.
[148] Gary S Francis,et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.
[149] E. McGee. Should moderate or greater mitral regurgitation be repaired in all patients with LVEF <30%? Surgery, mitral regurgitation, and heart failure: the valves are all repairable but the patients are not. , 2008, Circulation. Heart failure.
[150] M. Acker. Should moderate or greater mitral regurgitation be repaired in all patients with LVEF <30%? Mitral valve repair in patients with advanced heart failure and severe functional mitral insufficiency reverses left ventricular remodeling and improves symptoms. , 2008, Circulation. Heart failure.
[151] K. Serri,et al. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations , 2006, Heart.
[152] P. Ponikowski,et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. , 2006, European heart journal.
[153] L. Pierard,et al. Long-term outcome of patients with heart failure and dynamic functional mitral regurgitation. , 2005, European heart journal.
[154] Gideon Uretzky,et al. Modification of surgical planning based on cardiac multidetector computed tomography in reoperative heart surgery. , 2005, The Annals of thoracic surgery.
[155] M. Stefadouros,et al. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. , 2004, The Journal of heart valve disease.
[156] Philippe Ravaud,et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.
[157] E. Tuzcu,et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. , 2003, The New England journal of medicine.
[158] L. Kritharides,et al. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. , 2002, The American journal of cardiology.
[159] J. Thomas,et al. Prediction of thrombus-related mechanical prosthetic valve dysfunction using transesophageal echocardiography. , 2000, The American journal of cardiology.
[160] L. Sleeper,et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK? , 2000, Journal of the American College of Cardiology.
[161] V. Ferrero,et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. , 2000, The American journal of cardiology.
[162] U. Ikeda,et al. Endothelin production in pulmonary circulation of patients with mitral stenosis. , 1994, Circulation.
[163] M. Woo,et al. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. , 1991, The American journal of cardiology.
[164] M. Schwaiger,et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1987, The American journal of cardiology.
[165] R. Miller,et al. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. , 1976, The American journal of cardiology.
[166] P. Voisine,et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.
[167] J. Kirklin,et al. Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[168] G. Filippatos,et al. Indications and practical approach to non-invasive ventilation in acute heart failure , 2018, European heart journal.
[169] T. Anzai,et al. Prognostic Impact of Functional Mitral Regurgitation in Patients Admitted With Acute Decompensated Heart Failure. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[170] P. Sengupta,et al. Pulmonary hypertension in valvular disease: a comprehensive review on pathophysiology to therapy from the HAVEC Group. , 2015, JACC. Cardiovascular imaging.
[171] Samer A M Nashef,et al. EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[172] J. Parrillo,et al. Cardiogenic Shock , 2018, Journal of the American Heart Association.